Robinhood, Applovin jump as S&P 500 reshuffle boosts index entrants
Agilent Technologies (NYSE:A), a $36.5 billion life sciences company with a "GOOD" InvestingPro Financial Health score, saw its President and CEO Padraig McDonnell sell 2,000 shares of company stock on September 2, 2025, at a price of $124.88, for a total transaction value of $249,760. The stock, currently trading at $128.65, appears overvalued according to InvestingPro’s Fair Value analysis.
Following the transaction, McDonnell directly owns 33,448 shares of Agilent Technologies.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 28, 2025. The transaction was reported in a Form 4 filing with the Securities and Exchange Commission.
In other recent news, Agilent Technologies reported strong third-quarter earnings for 2025, with earnings per share (EPS) meeting expectations at $1.37. The company’s revenue outpaced forecasts, reaching $1.74 billion compared to the anticipated $1.67 billion. This performance was supported by a balanced global revenue distribution across the United States, Europe, and Asia, with notable growth in pharmaceutical markets and the Chemical & Advanced Materials segment. TD Cowen maintained its Buy rating on Agilent, setting a price target of $150, highlighting the company’s 6.1% organic growth, which exceeded the consensus expectation of 3.6%. Bernstein SocGen Group reiterated its Market Perform rating with a $125 price target, noting Agilent’s fifth consecutive quarter of sequential core revenue acceleration. KeyBanc also reiterated its Sector Weight rating following the earnings beat. These developments reflect Agilent’s ongoing market recovery and strong performance across its business segments.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.